The value of magnetic resonance imaging-ultrasound fusion targeted biopsies for clinical decision-making among patients with previously negative transrectal ultrasound biopsy and persistent prostate-specific antigen elevation.

Gillis, Charlie J; Southall, Thomas M; Wilson, Robert; Anderson, Michelle; Young, Jennifer; Hewitt, Richard; Andrews, Matthew

Gillis, Charlie J; Southall, Thomas M; Wilson, Robert; Anderson, Michelle; Young, Jennifer; Hewitt, Richard; Andrews, Matthew.

Afiliación

Gillis CJ; Department of Urology, Dalhousie University, Halifax, NS, Canada.
Southall TM; MemorialUniversity School of Medicine, St. John's, NL, Canada.
Wilson R; MemorialUniversity School of Medicine, St. John's, NL, Canada.
Anderson M; Department of Radiology, Health Sciences Centre, St. John's, NL, Canada.
Young J; Division of Urology, Department of Surgery, Health Sciences Centre, St. John's, NL, Canada.
Hewitt R; Division of Urology, Department of Surgery, Health Sciences Centre, St. John's, NL, Canada.
Andrews M; Division of Urology, Department of Surgery, Health Sciences Centre, St. John's, NL, Canada.

Can Urol Assoc J ; 16(6): E315-E320, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35099383

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Can Urol Assoc J Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google